What is the role of pharmacologic therapy in the management of moyamoya disease?

Updated: Nov 09, 2018
  • Author: Roy Sucholeiki, MD; Chief Editor: Amy Kao, MD  more...
  • Print

Pharmacologic therapy for moyamoya disease is disappointing. Therapy is primarily directed at complications of the disease. If intracerebral hemorrhage has occurred, then management of hypertension (if present) is imperative. In cases of severe stroke, intensive care unit (ICU) monitoring is indicated until the patient's condition stabilizes. If the patient has had an ischemic stroke, consider anticoagulation or antiplatelet agents.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!